NCT00938886View on ClinicalTrials.gov

Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions

Hazardous DrinkingCigarette Smoking

Interventions

DRUG

Naltrexone

Daily 50 mg naltrexone

DRUG

Placebo

Matched naltrexone placebo

Trial Locations (1)

02912

Brown University, Providence

Sponsors

Lead Sponsor

Brown University

All Listed Sponsors

lead

Brown University

OTHER

NCT00938886 - Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment | Biotech Hunter | Biotech Hunter